Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
West Columbia, SC NAICS: 325412
U.S. Department of Labor's OFLC discloses 12 Labor Condition Application filings naming Nephron Pharmaceuticals Corporation from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 10 H-1B petitions naming Nephron Pharmaceuticals Corporation through FY2023, and approved nearly every one of them: 100% approved (10 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Nephron Pharmaceuticals Corporation is listed in 12 DOL LCA filings, more filings than 87% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $64,693. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in West Columbia, SC.
Nephron Pharmaceuticals Corporation vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
12 16712th of 122824 higher than 106,112 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $49,920–$130,000 .
DOL LCA release change
On 12 LCAs with comparable offered vs prevailing wages, Nephron Pharmaceuticals Corporation averages about 18.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Entry (Level I) (83.3% of LCA filings).
Only 12 LCAs on file for Nephron Pharmaceuticals Corporation, and 75% land in LEXINGTON, SC. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$64,693
Below portal avg
Total Workers
12
Small worker count
Compensation range for H-1B positions at Nephron Pharmaceuticals Corporation
Wage vs. DOL Minimum
+18.2%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Entry (Level I)
83.3% of LCA filings
Full-Time Positions
100%
Primary Worksite County
LEXINGTON, SC
75% of LCA filings
Most frequently listed job titles at Nephron Pharmaceuticals Corporation
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Environmental Monitoring Technician | 4 | $51,480 |
| Microbiology QC Analyst | 3 | $54,080 |
| Senior Data Analyst | 1 | $97,000 |
| Senior Accountant | 1 | $75,000 |
| Procurement Generalist | 1 | $50,000 |
| Director of Document and Change Control | 1 | $130,000 |
| Analytical Chemist I | 1 | $56,160 |
Cross-state DOL neighbors for Nephron Pharmaceuticals Corporation - LCA filing-count and offered-wage axes, outside SC.
Nearest cross-state employer filers by LCA filing count (12 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($64,693 here).
Nephron Pharmaceuticals Corporation is listed in 12 DOL Labor Condition Application filings covering 12 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Nephron Pharmaceuticals Corporation ranks #15675 by total LCA filing count (12 filings). 106,112 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Nephron Pharmaceuticals Corporation has a 100% DOL certification rate, with 12 out of 12 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Nephron Pharmaceuticals Corporation's LCAs is $64,693. Listed wages range from $49,920 to $130,000 and are not verified actual compensation.
The top job titles in Nephron Pharmaceuticals Corporation's LCA filing records include Environmental Monitoring Technician, Microbiology QC Analyst, Senior Data Analyst. The most common listed title is Environmental Monitoring Technician with 4 LCA filings at an average listed offered wage of $51,480. This does not establish actual job openings, hiring, or approved petitions.
Nephron Pharmaceuticals Corporation is headquartered in West Columbia, SC.
No, Nephron Pharmaceuticals Corporation is not classified as H-1B dependent.
Nephron Pharmaceuticals Corporation is listed in 1 LCA filings in FY2023 and 4 in FY2026. The average listed offered wage changed from $56,160 to $53,040. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Nephron Pharmaceuticals Corporation); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Nephron Pharmaceuticals Corporation); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Nephron Pharmaceuticals Corporation); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Nephron Pharmaceuticals Corporation); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
SC pole at 641 LCAs stamps MID-BOOK · CERT-SOLID, farthest ABS(total_petitions) contrast from Nephron Pharmaceuticals Corporation's MICRO-BOOK.
Open the SC state board after the ABS peers. Nephron Pharmaceuticals Corporation stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Nephron Pharmaceuticals Corporation's WAGE-BELOW · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Nephron Pharmaceuticals Corporation to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.